Divis Laboratories Ltd vs Zydus Lifesciences Ltd
Side-by-side stock comparison based on AI earnings call analysis
Which stock has stronger management signals?
Zydus Lifesciences Ltd currently has the stronger revenue growth signal.
Divis Laboratories Ltd and Zydus Lifesciences Ltd show active capex signals based on earnings call analysis.
No strong fundraising signal is currently visible for either company.
| Metric | Divis Laboratories Ltd | Zydus Lifesciences Ltd |
|---|---|---|
| Current Price | ₹8,275 | ₹1,114 |
| Market Cap | ₹2.23 L Cr. | ₹1.12 L Cr. |
| Industry | Pharmaceuticals & Biotechnology | Pharmaceuticals & Biotechnology |
| P/E Ratio | 74.8 | 20.61 |
| ROE (%) | 16.53 | 21.25 |
| Debt/Equity | — | 0.46 |
| Sales Growth 5Y (%) | 8.67 | 12.45 |
| Profit Growth 5Y (%) | 39.23 | 26.23 |
| Promoter Holding (%) | 51.88 | 75.02 |
| Revenue Rank | Rank 3 | Rank 2 |
| Margin Rank | Rank 3 | Rank 4 |
| Signal | — | — |
| Capex | Yes | Yes |
| Fundraise | No information | No information |